## Abstract Glucocorticoid therapy is the most common cause of secondary iatrogenic osteoporosis. The bone loss occurs predominantly due to a decrease in bone formation, although increased bone resorption also occurs. Glucocorticoids induce osteoblast apoptosis and increase osteoclast survival and
Bisphosphonates and glucocorticoids: Effects on bone quality
β Scribed by Willem F. Lems
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 129 KB
- Volume
- 56
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Periprosthetic osteolysis and aseptic loosening of total joint replacements are believed to be initiated often by abnormal bone resorption induced by prosthetic wear debris. Bisphosphonates can inhibit bone resorption and have been successfully used clinically to treat osteoporosis and Paget's disea
## Background: Tumor-induced osteolysis due to breast carcinoma and myeloma is responsible for a considerable morbidity that severely impairs patients'quality of life. osteoclast-mediated bone resorption is reported to be increased markedly in patients with tumor bone disease and can be inhibited b
We developed a prepacked mixing system for the preparation of bone cement. The system is based on mixing and collection of bone cement under a vacuum and serves as both the storage and mixing device for the cement components, thereby minimizing the exposure of the operating staff to the monomer and
Glucocorticoid in excess produces bone loss in vivo. Consistent with this, it reduces the stimulatory effect of transforming growth factor β€ (TGF-β€) on collagen synthesis in osteoblast-enriched cultures in vitro, where it also suppresses TGF-β€ binding to its type I receptors. Analogous studies with